Zhicong Chen

6600 Nanfeng Road, Nanqiao New Town
Nanqiao, 201499, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair.

A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair.

Journal: Redox biology

Published: August 02, 2026

Correspondence on: 'Patient reported medication-related problems, adherence and waste of oral anticancer medication over time' by van den Bemt et al.

Correspondence on: 'Patient reported medication-related problems, adherence and waste of oral anticancer medication over time' by van den Bemt et al.

Journal: European journal of hospital pharmacy : science and practice

Published: December 18, 2024

Low opinion of generic oral anticancer drugs: an unacknowledged factor resulting in medication waste in China.

Low opinion of generic oral anticancer drugs: an unacknowledged factor resulting in medication waste in China.

Journal: The oncologist

Published: November 19, 2024

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system.

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system.

Journal: Frontiers in pharmacology

Published: October 26, 2024

HDC downregulation induced by chronic stress promotes ovarian cancer progression via the IL-6/STAT3/S100A9 pathway.

HDC downregulation induced by chronic stress promotes ovarian cancer progression via the IL-6/STAT3/S100A9 pathway.

Journal: Frontiers in pharmacology

Published: August 25, 2024

Chronic stress promotes non-small cell lung cancer (NSCLC) progression through circMBOAT2 upregulation mediated by CTCF.

Chronic stress promotes non-small cell lung cancer (NSCLC) progression through circMBOAT2 upregulation mediated by CTCF.

Journal: Cancer gene therapy

Published: April 16, 2024

Feasibility of Using Serum, Plasma, and Platelet 5-hydroxytryptamine as Peripheral Biomarker for the Depression Diagnosis and Response Evaluation to Antidepressants: Animal Experimental Study.

Feasibility of Using Serum, Plasma, and Platelet 5-hydroxytryptamine as Peripheral Biomarker for the Depression Diagnosis and Response Evaluation to Antidepressants: Animal Experimental Study.

Journal: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Published: January 18, 2024

Gastrodin alleviates the deterioration of depressive-like behavior and glucolipid metabolism promoted by chronic stress in type 2 diabetic mice.

Gastrodin alleviates the deterioration of depressive-like behavior and glucolipid metabolism promoted by chronic stress in type 2 diabetic mice.

Journal: European journal of pharmacology

Published: January 12, 2024

Corrigendum: Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota.

Corrigendum: Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota.

Journal: Frontiers in pharmacology

Published: October 11, 2023

Corrigendum: Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview.

Corrigendum: Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview.

Journal: Frontiers in pharmacology

Published: October 11, 2023

Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress.

Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress.

Journal: PeerJ

Published: May 01, 2023

Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview.

Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview.

Journal: Frontiers in pharmacology

Published: January 22, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026